Two Sigma Advisers’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-16,000
| Closed | -$74K | – | 2520 |
|
|
2019
Q1 | $74K | Buy |
16,000
+900
| +6% | +$4.16K | ﹤0.01% | 2215 |
|
|
2018
Q4 | $53K | Buy |
+15,100
| New | +$53K | ﹤0.01% | 2272 |
|
|
2017
Q1 | – | Sell |
-70,200
| Closed | -$646K | – | 2529 |
|
|
2016
Q4 | $646K | Buy |
70,200
+23,900
| +52% | +$220K | ﹤0.01% | 1745 |
|
|
2016
Q3 | $546K | Sell |
46,300
-44,400
| -49% | -$524K | ﹤0.01% | 1640 |
|
|
2016
Q2 | $1.17M | Sell |
90,700
-11,700
| -11% | -$151K | 0.01% | 1092 |
|
|
2016
Q1 | $1.64M | Buy |
102,400
+48,700
| +91% | +$779K | 0.01% | 885 |
|
|
2015
Q4 | $1.54M | Buy |
53,700
+46,600
| +656% | +$1.33M | 0.01% | 841 |
|
|
2015
Q3 | $214K | Sell |
7,100
-58,200
| -89% | -$1.75M | ﹤0.01% | 1615 |
|
|
2015
Q2 | $2.35M | Buy |
+65,300
| New | +$2.35M | 0.02% | 733 |
|
|
2014
Q2 | – | Sell |
-47,098
| Closed | -$976K | – | 2159 |
|
|
2014
Q1 | $976K | Buy |
+47,098
| New | +$976K | 0.01% | 912 |
|